Sort
23,748 grants matching “melanoma”
TESTING NEW DRUGS FOR TREATMENT OF MELANOMA PATIENTS APPLYING CONNECTIVITY MAP DATABASE ANALYSIS WITH MELANOMA GENE SIGNATURES
$130,495Beth Israel Deaconess Medical Center, Inc. · · FY2011 · Department of the Army
MicroRNA-Based Detection of Barriers to Melanoma Progression
$130,487Robert Laird Judson-Torres · University Of California, San Francisco · DP5 · FY2018 · OD
MELANOMA AND ALLELIC VARIATION IN THE MCIR GENE
$130,446University Of Pennsylvania · K07 · FY2004 · CA
Hemostatic Factors and Tumor Biology
$130,410Joseph S Palumbo · Cincinnati Childrens Hosp Med Ctr · K08 · FY2007 · HL
NEUROPATHOLOGY/TISSUE BANK CORE
$130,357Claudia Katharina Petritsch · Stanford University · U54 · FY2025 · CA
MRI CORE
$130,322Rheal A Towner · University Of Oklahoma Hlth Sciences Ctr · P20 · FY2008 · RR
Personalized targeting of anti-apoptosis pathways to overcome therapeutic resistance in melanoma
$130,262Michael Davies · Wistar Institute · U54 · FY2023 · CA
Project 2: TOPK/PRPK as Novel Targets for Skin Cancer Prevention
$130,137Rebecca Morris · University Of Arizona · P01 · FY2019 · CA
MELANOMA AND ALLELIC VARIATION IN THE MCIR GENE
$130,128University Of Pennsylvania · K07 · FY2003 · CA
Purification of a Novel Antibody Against Solid Organ Cancer Stem Cells
$130,092Itzhak Avital · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Melanoma NRAS/BRAF Mutations: A Population-Based Study
$130,058University Of North Carolina Chapel Hill · K07 · FY2003 · CA
Melanoma NRAS/BRAF Mutations: A Population-Based Study
$130,058Nancy E Thomas · Univ Of North Carolina Chapel Hill · K07 · FY2006 · CA
Melanoma NRAS/BRAF Mutations: A Population-Based Study
$130,058University Of North Carolina Chapel Hill · K07 · FY2004 · CA
Melanoma NRAS/BRAF Mutations: A Population-Based Study
$130,058Nancy E Thomas · Univ Of North Carolina Chapel Hill · K07 · FY2007 · CA
Melanoma NRAS/BRAF Mutations: A Population-Based Study
$130,058University Of North Carolina Chapel Hill · K07 · FY2005 · CA
The role of CD4+ T cells in melanoma immunotherapy
$130,019University Of Virginia Charlottesville · K01 · FY2003 · CA
MODULATION OF CLINICAL SENSITIVITY TO CHEMOTHERAPY
$129,924Dartmouth College · K24 · FY2002 · CA
MODULATION OF CLINICAL SENSITIVITY TO CHEMOTHERAPY
$129,924Dartmouth College · K24 · FY2001 · CA
MODULATION OF CLINICAL SENSITIVITY TO CHEMOTHERAPY
$129,924Dartmouth College · K24 · FY2004 · CA
MODULATION OF CLINICAL SENSITIVITY TO CHEMOTHERAPY
$129,924Dartmouth College · K24 · FY2000 · CA
CEA directed cancer treatment with gene-modified T cells
$129,924Mark Denton McKee · University Of Chicago · K08 · FY2007 · CA
MODULATION OF CLINICAL SENSITIVITY TO CHEMOTHERAPY
$129,924Dartmouth College · K24 · FY2003 · CA
Immunotherapy of tumor with A Novel Cytokine IL-21
$129,860University Of Texas Md Anderson Can Ctr · R21 · FY2005 · CA
ARF6 function in cancers driven by RAS hyperactivation
$129,824Jae Hyuk Yoo · University Of Utah · K99 · FY2019 · CA
ARF6 function in cancers driven by RAS hyperactivation
$129,824Jae Hyuk Yoo · University Of Utah · K99 · FY2018 · CA